Your AI-Trained Oncology Knowledge Connection!

News

Video

Strategies for Treating RAS-Mutated mCRC

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Shilpa Gupta, MD, director of Genitourinary Medical Oncology at the Taussig Cancer Institute and co-leader of the Genitourinary Oncology Program in the Department of Hematology and Medical Oncology, Cleveland Clinic; as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center
Hyun-Woong Cho, MD, PhD, Department of Obstetrics and Gynecology, Korea University College of Medicine
SHAH
Timothy S. Fenske, MD, MS
2 experts in this video
2 experts in this video
Sheela Rao, MBBS, MD, FRCP
Related Content
Shruti Patel, MD, clinical assistant professor, medicine-oncology, Stanford Medicine
March 21st 2025

Oncologists Call for Equity and Female Representation in Research During Women’s History Month

Ibrahim T. Aldoss, MD, associate professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope; Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
March 20th 2025

Ponatinib Monotherapy Maintains MRD Negativity Following TKI/Chemotherapy Treatment in Ph+ ALL: With Ibrahim T. Aldoss, MD; and Elias Jabbour, MD

Glioblastoma |Image Credit: © Sebastian Kaulitzki - stock.adobe.com
March 21st 2025

New Grant Funds First-of-Its-Kind Gene Therapy to Treat Aggressive Brain Cancer

D. Ross Camidge, MD, PhD; Alexandra Rink, PhD, medical physicist, Princess Margaret Cancer Centre, clinician scientist, Princess Margaret Research Institute, associate professor, Departments of Radiation Oncology and Medical Biophysics, University of Toronto
March 19th 2025

How Medical Physicists Contribute to Optimized Oncologic Outcomes: With D. Ross Camidge, MD, PhD; Alexandra Rink, PhD

Image credit: Nittaya – stock.adobe.co
March 21st 2025

NMPA Grants Conditional Approval to Tazemetostat for EZH2-Mutant R/R Follicular Lymphoma

Image credit: © TensorSpark – stock.adobe.com
March 21st 2025

PLN-101095/Pembrolizumab Has Early Activity in ICI-Refractory Advanced Solid Tumors